Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $550.66 | 42 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $213.66 | 25 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $78.92 | 3 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $53.13 | 3 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $50.22 | 2 | $0 (2024) |
| Alkermes, Inc. | $35.72 | 2 | $0 (2024) |
| Axsome Therapeutics, Inc. | $30.84 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $19.70 | 1 | $0 (2024) |
| Corium, LLC | $18.94 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.36 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $17.28 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $550.66 | 42 | ABBVIE INC. ($213.66) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.59 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Neurology | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: CNS | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.12 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Neuropsychiatry | ||||||
| 10/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/02/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: CNS | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $35.74 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: NEUROSCIENCE | ||||||
About Chrystal Pratt, CRNP
Chrystal Pratt, CRNP is a Psychiatric/Mental Health healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2024. The National Provider Identifier (NPI) number assigned to this provider is 1437919925.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Chrystal Pratt, CRNP has received a total of $550.66 in payments from pharmaceutical and medical device companies, with $550.66 received in 2024. These payments were reported across 42 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($550.66).
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Psychiatric/Mental Health
- Location Latrobe, PA
- Active Since 03/21/2024
- Last Updated 03/21/2024
- Taxonomy Code 163WP0808X
- Entity Type Individual
- NPI Number 1437919925
Products in Payments
- VRAYLAR (Drug) $213.66
- HETLIOZ (Drug) $78.92
- UZEDY (Drug) $53.13
- CAPLYTA (Drug) $50.22
- ARISTADA (Drug) $35.72
- Auvelity (Drug) $30.84
- INVEGA SUSTENNA (Drug) $19.70
- Azstarys (Drug) $18.94
- TRINTELLIX (Drug) $17.36
- ABILIFY MAINTENA (Drug) $17.28
- INGREZZA (Drug) $14.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.